This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A randomized, double-blind, parallel-group placebo...
Clinical trial

A randomized, double-blind, parallel-group placebo-controlled study of the safety and reduction of signs and symptoms during treatment with tocilizumab (TCZ) versus placebo in patients with ankylosing spondylitis who have had an inadequate response to pre

Read time: 1 mins
Last updated:9th Aug 2010
To assess the: efficacy of treatment with TCZ 4 mg/kg and 8 mg/kg versus placebo in AS patients who have had an inadequate response to TNF antagonist therapy with regard to the proportion of patients who achieve an ASAS20 response at week 12 (confirmation at week 24) and the safety of TCZ 4 mg/kg and 8 mg/kg versus placebo with regard to AEs and laboratory assessments
Category Value
Study start date 2010-08-09

View full details